[PDF] Top 20 Arq Bras Endocrinol Metab vol.50 número2

... (Arq Bras Endocrinol Metab 2006;50/2:198-207) Keywords: Natriuretic peptides; ANP, BNP and CNP; Guanylyl cyclase and clearance receptors; Blood pressure-volume homeostasis; Growth, hypertrophy ... See full document

... Esta revisão faz um apanhado dos agentes fisiológicos e terapêutica atual, bem como de medicações que têm sido usadas extensivamente e de outros agentes ainda não disponíveis ou que são consideradas dro- gas ... See full document

... Na edição de Abril de 2006, o artigo de Luciana Bahia e colaboradores — “O Endotélio na Síndrome Metabólica” (Arq Bras Endocrinol Metab 2006; 50/2:291-303), por uma falha na diagramação[r] ... See full document

... Of perhaps greater concern, at least in the con- text of osteoporosis, is the fact that, with the advent of potent bone active agents, the importance of calcium (and vitamin D) appears to have been lost sight of by both ... See full document

... U sing meta-analyses of population-based cohorts from Europe, North America, Asia, and Australia, the international validity of candidate risk factors for frac- ture was examined by a WH O task force at a conference held ... See full document

... Tumores marrons são relativamente incomuns mas constituem sérias complicações da osteodistrofia renal. Descrevemos o caso de uma paciente, 31 anos, com doença renal em estágio terminal, em hemo- diálise há nove anos, que ... See full document

... Objetivo: Analisar a relação entre obesidade e taxa de excreção urinária de albumina (TEUA). Métodos: Este é um estudo de corte de 73 pacientes com diabetes tipo 2 (DM) normoalbuminúricos (TEUA < 20 µg/min), que foram ... See full document

... Osteoporosis is a metabolic disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk. Bone fragility ... See full document

... From our cohort we evaluated the accuracy of this technique in 64 patients according to the clini- cal manifestation of the disease (20). The sestamibi scan was positive in 64% of asymptomatic patients, 83% of patients ... See full document

... The management of asymptomatic primary hyperparathyroidism has been addressed at two NIH conferences, one held in 1990 (32) and another more recently in 2002 (33). At the more recent conference (33), the 1990 guidelines ... See full document

... The WHI demonstrated unequivocally that estrogen, with or without progestin, reduced fracture risk. The WHI was a randomized, double blind placebo-con- trolled multicenter study. There were two studies, the first of ... See full document

... Antiresorptive agents for osteoporosis are a cornerstone of therapy, but anabolic drugs have recently widened our therapeutic options. By directly stimulating bone formation, anabolic agents reduce fracture incidence by ... See full document

... A osteoporose é definida como “uma doença esquelética sistêmica caracterizada por baixa massa óssea e deterioração da microarquite- tura do tecido ósseo com conseqüente aumento da susceptibilidade a fraturas”. ... See full document

... The efficacy of Ibandronate in treating post- menopausal osteoporosis was assessed in a random- ized, double-blind, placebo-controlled study conduct- ed in women with osteoporosis and 1 to 4 prevalent vertebral fractures ... See full document

... (33,34). In women with pre-existing vertebral frac- tures, alendronate therapy reduced the incidence of vertebral, hip and wrist fractures by about 50% (table 2), and the risk of multiple vertebral fractures was ... See full document

... Em artigo mais recente (4), onde foi realizado monitoramento contínuo da glicose com o objetivo de determinar a prevalência e extensão das excursões glicêmicas em pacientes portadores de[r] ... See full document

... Initial retrospective (107) and prospective studies (108,109) that compared tamoxifen-treated women against the placebo group, found no signifi- cant differences in BMD at the lumbar spine or femoral neck. Subsequent ... See full document

... não deixará de prover os recursos e meios para que o Corpo Editorial possa desenvolver adequadamente seu trabalho, que em última análise objetiva dar maior vi- sibilidade internacional à[r] ... See full document

... 5. Souza Rosario PW, Fagundes TA, Fagundes AS, Barroso AL, Lamego Rezende L, Lanza Padrão E, et al. Ovarian function after radioiodine therapy in patients with thy- roid cancer. Exp Clin Endocrinol Diabetes ... See full document

... (Arq Bras Endocrinol Metab 2006:50/ 2:) esta foi extensiva- mente estudada, mas, devido à ausência de trabalhos abordando sua relação com transtornos psiquiátricos, os autores se viram ... See full document